Higher baseline plasma levels of NfL were also associated with greater motor and cognitive decline after a follow-up period of 3 years in patients with PD, suggesting value of NfL as a predictive biomarker of disease severity and progression in this disease (Lin et al., 2019; Ma et al., 2021; Zhu et al., 2021). The gene discussed is NEFL; the disease is Mental deterioration.